Multiple DMARD discontinuations in rheumatoid arthritis: how often and in what patients? Results from a national clinical RA register
Objectives Multiple discontinuations of biologic (b-) or targeted synthetic (ts-) disease-modifying antirheumatic drugs (DMARDs) may indicate difficult-to-treat disease. We aimed to assess the occurrence of b/tsDMARD discontinuations in patients with rheumatoid arthritis (RA), specifically how this...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2025-11-01
|
| Seri Bilgileri: | RMD Open |
| Online Erişim: | https://rmdopen.bmj.com/content/11/4/e005617.full |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|